Press Release

 

OPM announces equity financing of up to 5 million euros
Financial
News
Press Release
Thu. 17 April 2025

OPM announces equity financing of up to 5 million euros

Read more
OPM announces its 2024 annual results and clinical developments
Financial
News
Press Release
Thu. 3 April 2025

OPM announces its 2024 annual results and clinical developments

Read more
OPM announces Protocol Submission for its Phase 1b/2a Study
News
Press Release
Mon. 24 March 2025

OPM announces Protocol Submission for its Phase 1b/2a Study

Read more
Nomination of Christophe Thurieau as an independent member of OPM Board of Directors
News
Press Release
Tue. 4 March 2025

Nomination of Christophe Thurieau as an independent member of OPM Board of Directors

Read more
4th Letter to Shareholders
News
Press Release
Mon. 6 January 2025

4th Letter to Shareholders

Read more
OPM reacquires rights to its OPM-201 program from Servier after a positive Phase I trial in healthy volunteers
News
Press Release
Fri. 20 December 2024

OPM reacquires rights to its OPM-201 program from Servier after a positive Phase I trial in healthy volunteers

Read more
OPM reports final results of its phase 1 study with RIPK2 inhibitor OPM-101
News
Press Release
Tue. 22 October 2024

OPM reports final results of its phase 1 study with RIPK2 inhibitor OPM-101

Read more
OPM announces poster presentation on OPM-101
News
Press Release
Tue. 15 October 2024

OPM announces poster presentation on OPM-101

Read more
OPM announces its first-half 2024 results and provides an update on its clinical developments, and its financial situation
Financial
News
Press Release
Wed. 25 September 2024

OPM announces its first-half 2024 results and provides an update on its clinical developments, and its financial situation

Read more